Endometriose

Einführung

Hintergrund. Obwohl die Endometriose erstmals bereits im späten 17. Jahrhundert beschrieben wurde, wird diese Erkrankung bis heute aufgrund des leider weitgehend fehlenden wissenschaftlichem und klinischem Interesses häufig als „forgotten disease” bezeichnet [1].

Selbst in aktuellen Abhandlungen über Erkrankungen des Menschen (Encyclopedia of Medical History, 1985 und The Cambridge World History of Human disease, 1993) sucht man vergebens nach einem Hinweis auf Endometriose [2] [3].

Aufgrund der hohen Prävalenz der Erkrankung erscheint dies verwunderlich. Ein Grund liegt sicherlich in der weitgehend unverstandenen Ätiologie sowie der schwierigen Diagnostik und Therapie dieser rätselhaften Erkrankung. Dieser Beitrag soll eine kurze, sicherlich nicht allumfassende Darstellung der Erkrankung geben, um die Erkrankung Endometriose vermehrt in den Mittelpunkt des klinischen und basiswissenschaftlichen Interesses zu rücken. Dies scheint aufgrund des hohen Leidensdruckes der Patientinnen sowie nicht zuletzt auch der hohen volkswirtschaftlichen Bedeutung dieser Erkrankung durch Arbeitsausfall und medizinischen Aufwand mehr als überfällig zu sein.

Literatur

• 1 Knapp V J. How old is endometriosis? Late 17^th- and 18^th-century European descriptions of the disease.  Fertil Steril. 1999;  72 10-14
• 2 Kiple K. The Cambridge world history of human disease. Cambridge University Press, Cambridge 1993
• 3 McGrew R. Encyclopedia of medical history. McGraw-Hill, New York 1985
• 4 Mahmood T A, Templeton A. Prevalence and genesis of endometriosis.  Hum Reprod. 1991;  6 544-549
• 5 Moen M H, Schei B. Epidemiology of endometriosis in a Norwegian county.  Acta Obstet Gynecol Scand. 1997;  76 559-562
• 6 Vigano P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors.  Best Pract Res Clin Obstet Gynaecol. 2004;  18 177-200
• 7 Witz C A, Burns W N. Endometriosis and infertility: is there a cause and effect relationship?.  Gynecol Obstet Invest. 2002;  53 Suppl 1 2-11
• 8 Simpson J L, Elias S, Malinak L R, Buttram V CJr. Heritable aspects of endometriosis. I. Genetic studies.  Am J Obstet Gynecol. 1980;  137 327-331
• 9 Meyer R. Über den Stand der Frage der Adenomyositis, Adenomyome im Allgemeinen und insbesondere über Adenomyositis seroepithelialis und Adenomyometritis sarcomatosa.  Zentralbl Gynäkol. 1919;  36 745-750
• 10 Sampson J. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity.  Am J Obst Gynecol. 1927;  14 442-469
• 11 D'Hooghe T M, Bambra C S, Raeymaekers B M. et al . Intrapelvic injection of menstrual endometrium causes endometriosis in baboons (Papio cynocephalus and Papio anubis).  Am J Obstet Gynecol. 1995;  173 125-134
• 12 Sharpe-Timms K L. Using rats as a research model for the study of endometriosis.  Ann N Y Acad Sci. 2002;  955 318-327 , discussion 340-312, 396-406
• 13 American Society for Reproductive Medicine . Revised American Society for Reproductive Medicine classification of endometriosis: 1996.  Fertil Steril. 1997;  67 817-821
• 14 Tuttlies F, Keckstein J, Ulrich U. et al . ENZIAN-score, a classification of deep infiltrating endometriosis.  Zentralbl Gynäkol. 2005;  127 275-281
• 15 Schweppe K W. Endometriosis - a disease that has no lobby.  Zentralbl Gynäkol. 2003;  125 233
• 16 Renner S P, Strick R, Oppelt P. et al . Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis.  Reproduction. 2006;  131 153-161
• 17 Sallam H, Garcia-Velasco J, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev: CD004635, 2006
• 18 Alborzi S, Momtahan M, Parsanezhad M E. et al . A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas.  Fertil Steril. 2004;  82 1633-1637
• 19 Saleh A, Tulandi T. Reoperation after laparoscopic treatment of ovarian endometriomas by excision and by fenestration.  Fertil Steril. 1999;  72 322-324
• 20 Hart R, Hickey M, Maouris P. et al .Excisional surgery versus ablative surgery for ovarian endometriomata. The Cochrane Database Syst Rev 2005, Issue 3. Art. No.: CD004992. DOI: 10.1002/14651858.CD004992.pub2, 2005
• 21 Mueller A, Thiel F, Binder H. et al . GebFra Refresher Myome - Teil 1.  Geburtsh Frauenheilk. 2004;  64 R229-R244
• 22 Mueller A, Oppelt P, Ackermann S. et al . The Hohl instrument for optimizing total laparoscopic hysterectomy procedures.  J Minim Invasive Gynecol. 2005;  12 432-435
• 23 Mueller A, Thiel F, Binder H. et al . GebFra Refresher Myome - Teil 2.  Geburtsh Frauenheilk. 2004;  64 R245-R260
• 24 Schweppe K W. Guidelines for the use of GnRH-analogues in the treatment of endometriosis.  Zentralbl Gynäkol. 2005;  127 308-313
• 25 Zupi E, Marconi D, Sbracia M. et al . Add-back therapy in the treatment of endometriosis-associated pain.  Fertil Steril. 2004;  82 1303-1308
• 26 Busacca M, Somigliana E, Bianchi S. et al . Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III-IV: a randomized controlled trial.  Hum Reprod. 2001;  16 2399-2402
• 27 Hornstein M D, Yuzpe A A, Burry K A. et al . Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain.  Fertil Steril. 1995;  63 955-962
• 28 Vercellini P, Crosignani P G, Fadini R. et al . A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis.  Br J Obstet Gynaecol. 1999;  106 672-677
• 29 Hornstein M D, Hemmings R, Yuzpe A A, Heinrichs W L. Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis.  Fertil Steril. 1997;  68 860-864
• 30 Hornstein M D, Surrey E S, Weisberg G W, Casino L A. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.  Obstet Gynecol. 1998;  91 16-24
• 31 Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev: CD001019, 2000
• 32 Fedele L, Berlanda N. Emerging drugs for endometriosis.  Expert Opin Emerg Drugs. 2004;  9 167-177
• 33 Goretzlehner G. Menstrual bleeding - must that be? Extended use of oral hormonal contraceptives.  Zentralbl Gynäkol. 2005;  127 302-307
• 34 Anderson F D, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive.  Contraception. 2003;  68 89-96
• 35 Mahutte N G, Arici A. Medical management of endometriosis-associated pain.  Obstet Gynecol Clin North Am. 2003;  30 133-150
• 36 Prentice A, Deary A J, Bland E. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev: CD002122, 2000
• 37 Regidor P A, Regidor M, Schmidt M. et al . Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.  Gynecol Endocrinol. 2001;  15 202-209
• 38 Vercellini P, Fedele L, Pietropaolo G. et al . Progestogens for endometriosis: forward to the past.  Hum Reprod Update. 2003;  9 387-396
• 39 Vercellini P, Vigano P, Somigliana E. The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis.  Curr Opin Obstet Gynecol. 2005;  17 359-365
• 40 Petta C A, Ferriani R A, Abrao M S. et al . Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.  Hum Reprod. 2005;  20 1993-1998
• 41 Allen C, Hopewell S, Prentice A, Allen C. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev: CD004753, 2005
• 42 Sagsveen M, Farmer J E, Prentice A, Breeze A. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev: CD001297, 2003
• 43 Attar E, Bulun S E. Aromatase and other steroidogenic genes in endometriosis: translational aspects.  Hum Reprod Update. 2005;  12 49-56
• 44 Ebert A D, Bartley J, David M. Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions - old answers?.  Eur J Obstet Gynecol Reprod Biol. 2005;  122 144-150
• 45 Pritts E A, Taylor R N. An evidence-based evaluation of endometriosis-associated infertility.  Endocrinol Metab Clin North Am. 2003;  32 653-667
• 46 Omland A K, Tanbo T, Dale P O, Abyholm T. Artificial insemination by husband in unexplained infertility compared with infertility associated with peritoneal endometriosis.  Hum Reprod. 1998;  13 2602-2605
• 47 Wu M Y, Ho H N. The role of cytokines in endometriosis.  Am J Reprod Immunol. 2003;  49 285-296
• 48 Kissler S, Hamscho N, Zangos S. et al . Diminished pregnancy rates in endometriosis due to impaired uterotubal transport assessed by hysterosalpingoscintigraphy.  Brit J Obstet Gynaecol. 2005;  112 1391-1396
• 49 Garrido N, Navarro J, Garcia-Velasco J. et al . The endometrium versus embryonic quality in endometriosis-related infertility.  Hum Reprod Update. 2002;  8 95-103
• 50 Garcia-Velasco J A, Mahutte N G, Corona J. et al . Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study.  Fertil Steril. 2004;  81 1194-1197
• 51 Simon C, Gutierrez A, Vidal A. et al . Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation.  Hum Reprod. 1994;  9 725-729
• 52 Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization.  Fertil Steril. 2002;  77 1148-1155
• 53 Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev 2000, Issue 2. Art. No.: CD003678. DOI: 10.1002/14651858.CD003678, 2000
• 54 Hughes E, Fedorkow D, Collins J, Vandekerckhove P. Ovulation suppression for endometriosis. Cochrane Database Syst Rev 2003, Issue 3. Art. No.: CD000155. DOI: 10.1002/14651858.CD000155, 2003
• 55 Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis.  Fertil Steril. 2002;  78 757-762
• 56 Hughes E G, Fedorkow D M, Collins J A. A quantitative overview of controlled trials in endometriosis-associated infertility.  Fertil Steril. 1993;  59 963-970
• 57 Jacobson T, Barlow D, Koninckx P. et al .Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev 2002, Issue 4. Art. No.: CD001398. DOI: 10.1002/14651858.CD001398, 2002
• 58 Strowitzki T. Infertility treatment and endometriosis - risk and benefit of assisted reproductive techniques.  Zentralbl Gynäkol. 2005;  127 314-319
• 59 Deaton J L, Gibson M, Blackmer K M. et al . A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis.  Fertil Steril. 1990;  54 1083-1088
• 60 Tummon I S, Asher L J, Martin J S, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis.  Fertil Steril. 1997;  68 8-12
• 61 Jansen R P. Relative infertility: modeling clinical paradoxes.  Fertil Steril. 1993;  59 1041-1045
• 62 Somigliana E, Vercellini P, Vigano P. et al . Should endometriomas be treated before IVF-ICSI cycles?.  Hum Reprod Update. 2005;  12 57-64